Eurofins Scientific SE Stock Deutsche Boerse AG
Stocks
ESF
FR0000038259
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Deutsche Boerse AG
05/02/2024
|
5-day change | 1st Jan Change | ||
| 53.62 EUR | -1.07% |
|
-4.59% | -9.73% |
| Market Cap | 13.67B 15.54B 12.92B 11.72B 22.01B 1,492B 22.14B 155B 59.76B 761B 58.34B 57.07B 2,446B | P/E 2026 * |
26.2x | P/E 2027 * | 20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 17.03B 19.37B 16.11B 14.61B 27.43B 1,859B 27.59B 193B 74.47B 949B 72.7B 71.13B 3,048B | EV / Sales 2026 * |
2.25x | EV / Sales 2027 * | 2.09x |
| Free-Float |
60.39% | Yield 2026 * |
1.02% | Yield 2027 * | 1.15% |
Last Transcript: Eurofins Scientific SE
| 1 day | -1.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 54 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.07% | -4.59% | - | - | 15.54B | |
| -0.21% | +3.73% | +12.31% | +37.17% | 49.06B | |
| +0.22% | +0.40% | +50.91% | +37.06% | 44.6B | |
| -1.58% | +4.66% | +359.34% | +614.38% | 43.24B | |
| +1.70% | +0.36% | +12.56% | +99.27% | 41.73B | |
| +0.51% | -1.71% | +5.18% | +46.87% | 29.93B | |
| -0.48% | -1.32% | +23.98% | +150.01% | 17.19B | |
| +0.08% | +9.03% | +8.41% | - | 15.35B | |
| -2.34% | -2.68% | +26.38% | +43.63% | 15.54B | |
| +1.97% | -3.17% | - | - | 15.11B | |
| Average | -0.12% | +1.85% | +62.38% | +146.91% | 30.19B | |
| Weighted average by Cap. | -0.05% | +2.26% | +78.10% | +160.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.58B 8.62B 7.17B 6.5B 12.22B 828B 12.29B 85.86B 33.16B 422B 32.37B 31.67B 1,357B | 8B 9.09B 7.56B 6.86B 12.88B 873B 12.96B 90.55B 34.97B 445B 34.14B 33.4B 1,431B |
| Net income | 531M 604M 502M 455M 855M 57.95B 860M 6.01B 2.32B 29.57B 2.27B 2.22B 95.02B | 660M 750M 624M 566M 1.06B 72B 1.07B 7.47B 2.88B 36.74B 2.82B 2.76B 118B |
| Net Debt | 3.37B 3.83B 3.18B 2.89B 5.42B 367B 5.45B 38.11B 14.72B 187B 14.37B 14.06B 602B | 3.03B 3.45B 2.87B 2.6B 4.89B 331B 4.91B 34.35B 13.27B 169B 12.95B 12.67B 543B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
- ESF Stock
Select your edition
All financial news and data tailored to specific country editions
